Revance Therapeutics (NASDAQ:RVNC) reported its Q3 earnings results on Wednesday, November 8, 2023 at 04:10 PM.

Here's what investors need to know about the announcement.

Earnings

Revance Therapeutics beat estimated earnings by 38.89%, reporting an EPS of $-0.55 versus an estimate of $-0.9.

Revenue was up $27.76 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.03 which was followed by a 8.05% drop in the share price the next day.

Here's a look at Revance Therapeutics's past performance:

To track all earnings releases for Revance Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.